Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G B Ratto

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
The Annals of Thoracic Surgery|February 1, 1991
Chest wall involvement by lung cancer: computed tomographic detection and results of operationG B Ratto, G Piacenza, C Frola, et al.
Anticancer Research|January 30, 2003
Phase II study of neoadjuvant chemotherapy in patients with surgically-proven, unresectable stage III non-small cell lung cancerF Grossi, M C Pennucci, J Serrano, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Phase II study of combined immunotherapy, chemotherapy, and radiotherapy in the postoperative treatment of advanced non-small-cell lung cancerG B Ratto, M A Cafferata, T Scolaro, et al.
Cancer|May 15, 1993
In situ lung perfusion with cisplatin. An experimental studyG B Ratto, M Esposito, A Leprini, et al.
Cancer|July 15, 1996
A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung carcinomaG B Ratto, P Zino, S Mirabelli, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 1, 1995
Immunotherapy with the use of tumor-infiltrating lymphocytes and interleukin-2 as adjuvant treatment in stage III non-small-cell lung cancer. A pilot studyG B Ratto, G Melioli, P Zino, et al.
Minerva Medica|January 14, 1983
[Artificial blood. Experimental studies on fluorocarbons as chemical blood substitutes]G Motta, A Grunert, M Herrmann, et al.
International Journal of Immunopathology and Pharmacology|January 11, 2012
Neo-adjuvant chemo/immunotherapy in the treatment of stage III (N2) non-small cell lung cancer: a phase I/II pilot studyG B Ratto, R Costa, P Maineri, et al.
European Journal of Cancer (Oxford, England : 1990)|May 24, 2003
Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancersF Grossi, M Loprevite, M Chiaramondia, et al.
Anticancer Research|March 4, 2000
Adoptive immunotherapy of advanced solid tumors: an eight year clinical experienceC Semino, L Martini, P Queirolo, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
The Annals of Thoracic Surgery|February 1, 1991
Chest wall involvement by lung cancer: computed tomographic detection and results of operationG B Ratto, G Piacenza, C Frola, et al.
Anticancer Research|January 30, 2003
Phase II study of neoadjuvant chemotherapy in patients with surgically-proven, unresectable stage III non-small cell lung cancerF Grossi, M C Pennucci, J Serrano, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Phase II study of combined immunotherapy, chemotherapy, and radiotherapy in the postoperative treatment of advanced non-small-cell lung cancerG B Ratto, M A Cafferata, T Scolaro, et al.
Cancer|May 15, 1993
In situ lung perfusion with cisplatin. An experimental studyG B Ratto, M Esposito, A Leprini, et al.
Cancer|July 15, 1996
A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung carcinomaG B Ratto, P Zino, S Mirabelli, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 1, 1995
Immunotherapy with the use of tumor-infiltrating lymphocytes and interleukin-2 as adjuvant treatment in stage III non-small-cell lung cancer. A pilot studyG B Ratto, G Melioli, P Zino, et al.
Minerva Medica|January 14, 1983
[Artificial blood. Experimental studies on fluorocarbons as chemical blood substitutes]G Motta, A Grunert, M Herrmann, et al.
International Journal of Immunopathology and Pharmacology|January 11, 2012
Neo-adjuvant chemo/immunotherapy in the treatment of stage III (N2) non-small cell lung cancer: a phase I/II pilot studyG B Ratto, R Costa, P Maineri, et al.
European Journal of Cancer (Oxford, England : 1990)|May 24, 2003
Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancersF Grossi, M Loprevite, M Chiaramondia, et al.
Anticancer Research|March 4, 2000
Adoptive immunotherapy of advanced solid tumors: an eight year clinical experienceC Semino, L Martini, P Queirolo, et al.
Pageof 10